HLA-A2-targeting T cells (Juno)

N/A

Report date: 2022/03/04 16:07:36

Base Information

Drug NameHLA-A2-targeting T cells (Juno)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy

Mechanisms of ActionHLA Class I Histocompatibility Antigen, A-2 alpha Chain inhibitors

TargetsHLA Class I Histocompatibility Antigen, A-2 alpha Chain

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsLeukemia

ATC CodeN/A